Peutz-Jeghers Syndrome, general aspects
Keywords:
Genetic mutations, Hereditary, Mucocutaneous pigmentation, Peutz Jeghers syndromeAbstract
Peutz Jeghers syndrome (SPJ) is a rare and hereditary syndromic pathology. It begins with mucocutaneous pigmentation associated with gastrointestinal hamartoma polyps, plus an elevated risk of cancer of the digestive tract. It is known that approximately 70% of the disease is hereditary and 30% is due to genetic mutations. Diagnosis lies in the medical history, physical examination and histological studies. According to the debut of the pathology, the specific treatment is established. The prognosis is reserved due to the high risk of malignancy. Being a rare pathology, and of scarce current literature in our local environment, it is necessary to carry out an updated review that addresses general aspects of the SPJ.Metrics
Metrics Loading ...
Downloads
Published
2019-06-30
How to Cite
Castillo-Riascos, G. A. ., & Ojeda-Luzuriaga, J. K. . (2019). Peutz-Jeghers Syndrome, general aspects. CEDAMAZ, 9(1), 49–52. Retrieved from https://revistas.unl.edu.ec/index.php/cedamaz/article/view/703
Issue
Section
Review Articles
License
Copyright (c) 2019 CEDAMAZ
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Those authors who have publications with this journal, accept the following terms:
- After the scientific article is accepted for publication, the author agrees to transfer the rights of the first publication to the CEDAMAZ Journal, but the authors retain the copyright. The total or partial reproduction of the published texts is allowed as long as it is not for profit. When the total or partial reproduction of scientific articles accepted and published in the CEDAMAZ Journal is carried out, the complete source and the electronic address of the publication must be cited.
- Scientific articles accepted and published in the CEDAMAZ journal may be deposited by the authors in their entirety in any repository without commercial purposes.
- Authors should not distribute accepted scientific articles that have not yet been officially published by CEDAMAZ. Failure to comply with this rule will result in the rejection of the scientific article.
- The publication of your work will be simultaneously subject to the Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)